⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5230 | 0.97 | SPHK2 (0.37) | — | |
| SCHEMBL4978 | 0.97 | SPHK2 (0.37) | — | |
| SCHEMBL5386 | 0.97 | SPHK2 (0.37) | — | |
| SCHEMBL5168 | 0.94 | — | — | |
| SCHEMBL127921 | 0.88 | — | — | |
| SCHEMBL7303667 | 0.82 | SPHK2 (0.35) | — | |
| SCHEMBL20531 | 0.82 | CTSL (0.38) | — | |
| SCHEMBL23039739 | 0.79 | CTSL (0.41) | — | |
| SCHEMBL16239892 | 0.79 | CTSL (0.41) | — | |
| SCHEMBL869115 | 0.79 | CTSL (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 292 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024062300-A1 | BIODEGRADABLE ELASTOMERIC COPOLYMER | SDIP Innovations Pty Ltd (AU) | 2024-03-28 | — | — | WO | disclosed |
| WO-2024058975-A1 | MODIFIED CHOLIC ACID CONJUGATES | ULTRA, LLC (US) | 2024-03-21 | — | — | WO | disclosed |
| US-20230109663-A1 | CONJUGATED POLYMERS AND METHODS OF USE | BioLegend, Inc. (US) | 2023-04-06 | — | — | US | disclosed |
| US-11584883-B2 | Conjugated polymers and methods of use | BioLegend, Inc. (US) | 2023-02-21 | — | — | US | disclosed |
| EP-3974496-B1 | CONJUGATED POLYMERS AND METHODS OF USE | BIOLEGEND INC (US) | 2022-12-14 | — | — | EP | disclosed |
| US-20220002552-A1 | SUBSTITUTED POLYFLUORENE COMPOUNDS | BioLegend, Inc. (US) | 2022-01-06 | — | — | US | disclosed |
| EP-3658648-B1 | CONJUGATED POLYMERS AND METHODS OF USE | BIOLEGEND INC (US) | 2021-10-27 | — | — | EP | disclosed |
| US-11155714-B2 | Substituted polyfluorene compounds | BioLegend, Inc. (US) | 2021-10-26 | — | — | US | disclosed |
| EP-3590940-B1 | HEXAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AND RELATED COMPOUNDS AS AUTOTAXIN (ATX) INHIBITORS AND AS INHIBITORS OF THE LYSOPHOSPHATIDIC ACID (LPA) PRODUCTION FOR TREATING E.G. RENAL DISEASES | HOFFMANN LA ROCHE (CH) | 2021-06-09 | — | — | EP | disclosed |
| US-10988687-B2 | Phthalocyanine formulation and uses thereof | LI-COR, INC. (US) | 2021-04-27 | — | — | US | disclosed |
| EP-0960096-A1 | SUBSTITUTED $g(b)-THIOCARBOXYLIC ACIDS | RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) | 1999-12-01 | — | — | EP | disclosed |
| WO-1999048870-A1 | PIPERIDIDINYL AND N-AMIDINOPIPERIDINYL DERIVATIVES | AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) | 1999-09-30 | — | — | WO | disclosed |
| WO-1999038844-A1 | METHOD FOR PREPARING AN N-[(ALIPHATIC OR AROMATIC)CARBONYL]-2-AMINOACETAMIDE COMPOUND AND A CYCLYZED COMPOUND | AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) | 1999-08-05 | — | — | WO | disclosed |
| EP-0871439-A4 | SUBSTITUTED (ARYL, HETEROARYL, ARYLMETHYL OR HETEROARYLMETHYL) HYDROXAMIC ACID COMPOUNDS | RHONE POULENC RORER PHARMA (US) | 1999-07-21 | — | — | EP | disclosed |
| WO-1999031491-A1 | METHOD AND REAGENTS FOR THE QUANTIFICATION OF SOLID-PHASE REACTIONS USING FLUORINE NMR | AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) | 1999-06-24 | — | — | WO | disclosed |
| WO-1999025752-A1 | FUNCTIONALIZED RESIN FOR THE SYNTHESIS OF AMIDES AND PEPTIDES | AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) | 1999-05-27 | — | — | WO | disclosed |
| EP-0871439-A1 | SUBSTITUTED (ARYL, HETEROARYL, ARYLMETHYL OR HETEROARYLMETHYL) HYDROXAMIC ACID COMPOUNDS | RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) | 1998-10-21 | — | — | EP | disclosed |
| WO-1998032734-A1 | SUBSTITUTED β-THIOCARBOXYLIC ACIDS | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1998-07-30 | — | — | WO | disclosed |
| WO-1997024117-A1 | SUBSTITUTED (ARYL, HETEROARYL, ARYLMETHYL OR HETEROARYLMETHYL) HYDROXAMIC ACID COMPOUNDS | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1997-07-10 | — | — | WO | disclosed |
| EP-0400519-A1 | 2-Hydroxy-n-propylamines, medicaments containing these compounds and method for preparing them | Dr. Karl Thomae GmbH (DE) | 1990-12-05 | — | — | EP | disclosed |